Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow

Mi Ji Lee1, Oh Young Bang, Suk Jae Kim

  • 1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Insights

Statin use before stroke in atrial fibrillation (AF) patients was linked to better collateral blood flow. This suggests statins might benefit AF-related cardioembolic stroke, despite trial exclusions.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Intensive lipid lowering is standard for atherosclerotic stroke.
  • The role of statins in cardioembolic stroke remains unclear.
  • This study examines statin association with collateral status in cardioembolic stroke.

Purpose of the Study:

  • To investigate the relationship between statin use and pretreatment collateral status in patients with cardioembolic stroke.
  • To assess if statin use influences collateral circulation in acute middle cerebral artery infarction due to atrial fibrillation.

Main Methods:

  • A collaborative study included 98 patients with acute middle cerebral artery infarction due to atrial fibrillation (AF).
  • Cerebral angiography was used to evaluate angiographic collateral grade (ASITN/SIR system).
  • The association between collateral grade and statin use/dose at stroke onset was analyzed.

Main Results:

  • Statin users (22/98) were older and had more comorbidities than statin-naïve patients (76/98).
  • Excellent collaterals (grade 3-4) were more frequent in statin users (50%) versus statin-naïve patients (27.6%; p=0.049).
  • Prestroke statin use was independently associated with excellent collaterals (OR, 7.841; p=0.004).

Conclusions:

  • Premorbid statin use in AF patients correlates with excellent collateral flow.
  • Findings suggest potential benefits of statins in AF-related cardioembolic stroke.
  • Further research is warranted given trial exclusions of cardioembolic stroke patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495